SNU-5 Cells
USD$540.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The SNU-5 cell line is a human gastric carcinoma model established from a metastatic lesion. It has been characterized for its molecular abnormalities, particularly those involving the p53 tumor suppressor gene. Studies show that SNU-5 exhibits a deletion of the p53 gene transcript, as determined by the absence of p53 mRNA in Northern blot analyses. This loss was further supported by RNase protection assays and sequencing, which revealed that SNU-5 lacks detectable mutations in the coding regions but fails to express the transcript altogether, indicating a possible regulatory or epigenetic mechanism of gene silencing rather than a structural mutation. Proteomic analyses have provided deeper insights into the molecular characteristics of SNU-5. Large-scale studies have included SNU-5 among a panel of cancer cell lines used to map the human cancer cell line proteome. In this context, SNU-5 contributes to datasets integrating mass spectrometry-based quantification of thousands of proteins. These proteomic datasets have been correlated with transcriptomic, genomic, and phenotypic profiles, offering a comprehensive view of protein expression, post-transcriptional regulation, and drug response characteristics. Such datasets position SNU-5 as a valuable model for investigating gastric cancer biology, especially in the context of metastatic disease and p53 pathway dysregulation. |
|---|---|
| Organism | Human |
| Tissue | Gastric |
| Disease | Adenocarcinoma |
| Metastatic site | Ascites |
| Applications | 3D cell culture, Cancer research |
| Synonyms | SNU5, NCI-SNU-5 |
Characteristics
| Age | 33 years |
|---|---|
| Gender | Female |
| Ethnicity | Korean |
| Morphology | Lymphoblast-like |
| Cell type | Lymphoblast |
| Growth properties | Adherent |
Regulatory Data
| Citation | SNU-5 (Cytion catalog number 305633) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0078 |
| GMO Status | GMO-S1: This 4T1 carcinoma derivative contains a-Luc reporter construct introduced by lentiviral transduction, enabling bioluminescent tumor monitoring. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Mutational profile | Mutation: CDKN2A, Simple, p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T), Homozygous; Mutation: TP53, Simple, p.Gly262_Ser269delGlyAsnLeuLeuGlyArgAsnSer (c.784_807del24), Unspecified |
|---|
Handling
| Culture Medium | IMDM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 25 mM HEPES, w: 1.0 mM Sodium pyruvate, w: 3.024 g/L NaHCO3 (Cytion article number 820800a) |
|---|---|
| Supplements | Supplement the medium with 20% FBS |
| Dissociation Reagent | Accutase |
| Doubling time | 34 hours |
| Subculturing | Collect the cells into 15ml tube and centrifue, aspirate the culture medium, resuspend the pellets, dispense the cells into the culture flask |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305633-121225 | Certificate of Analysis | 22. Jan. 2026 | 305633 |
-
Related products
Related products
SNU-601 CellsOrganism Human Tissue Stomach Disease Gastric signet ring cell adenocarcinoma USD$550.00*